Home Newsfeeds CNBC Reported Monday, SpaceX to Raise $750M at $137B Valuation

CNBC Reported Monday, SpaceX to Raise $750M at $137B Valuation

https://www.cnbc.com/2023/01/02/spacex-raising-750-million-at-137-billion-valuation-a16z-investing.html

byCharles Gross

January 3, 2023

1 minute read

https://www.cnbc.com/2023/01/02/spacex-raising-750-million-at-137-billion-valuation-a16z-investing.html

Bitcoin Hovers Near $30K After BitGo Abandons Prime Trust Takeover, Ethereum, Dogecoin Drop Slightly — Analyst Predicts 420% Surge For King Crypto By 2025

By Mehab Qureshi

June 22, 10:33 PM

Major cryptocurrencies slightly tumbled on Thursday evening following BitGo’s decision to halt the acquisition of rival Prime

$DOGE

Goldman Sachs Initiates Coverage On Prime Medicine with Neutral Rating, Announces Price Target of $22

By Benzinga Newsdesk

November 14, 5:59 AM

Goldman Sachs analyst Salveen Richter initiates coverage on Prime Medicine (NASDAQ:PRME) with a Neutral rating and announces Price Target of $22.

PRME

Actinium Pharma Highlights Six Abstracts Accepted For Oral And Poster Presentation At The SNMMI 2023 Annual Meeting

By Benzinga Newsdesk

June 23, 8:05 AM

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today details the six abstracts accepted for oral and poster presentation at the upcoming

ATNM

General
News

Stellantis Picks Second Plant To Produce EVs Under STLA Large platform – This Time In Italy

By Shivani Kumaresan

March 9, 12:54 PM

Stellantis NV (NYSE:STLA) said its Cassino Assembly Plant in Italy would produce vehicles based on the flexible, BEV-centric STLA Large…

STLA

CNBC Reported Monday, SpaceX to Raise $750M at $137B Valuation

Related Posts

Bitcoin Hovers Near $30K After BitGo Abandons Prime Trust Takeover, Ethereum, Dogecoin Drop Slightly — Analyst Predicts 420% Surge For King Crypto By 2025

Goldman Sachs Initiates Coverage On Prime Medicine with Neutral Rating, Announces Price Target of $22

Actinium Pharma Highlights Six Abstracts Accepted For Oral And Poster Presentation At The SNMMI 2023 Annual Meeting

Stellantis Picks Second Plant To Produce EVs Under STLA Large platform – This Time In Italy